Magenta Medical, Developer of World’s Smallest Heart Pump, Closes $105M Financing Round
DAIC
JULY 29, 2024
MCS is one of the fastest growing markets in interventional cardiology. FDA for two clinical indications: high-risk percutaneous coronary intervention (HR-PCI) and cardiogenic shock (CS). Because of these potential advantages, Magenta's Elevate System was granted Breakthrough Device Designation by the U.S.
105 
Let's personalize your content